Samuel Alonso is an accomplished Finance Director currently at Lesaffre Ibérica, where they have been leading since 2016. They previously served as Chief Executive Officer at Antartis Pharma from 2008 to 2017 and held roles on boards, including Hunan Norchem Pharmaceutical Co. Ltd. and Gadea Grupo Farmacéutico, contributing to various strategic initiatives. Samuel has extensive academic credentials, including a Licentiate degree in Economics and Business Administration from Universidad de Valladolid and multiple advanced programs at prestigious institutions like IESE Business School and San Telmo Business School. They have also contributed to academia as a Professor of Finance at Salamanca University from 2017 to 2020.
This person is not in the org chart
This person is not in any teams
This person is not in any offices